Ann Dermatol.  2015 Feb;27(1):109-110. 10.5021/ad.2015.27.1.109.

Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis

• Kim G
• Jeong YI
• Huh JW
• Kim EJ
• Joh OJ

• KMID: 2264854
• DOI: http://doi.org/10.5021/ad.2015.27.1.109

Abstract

No abstract available.

MeSH Terms

Humans
Interferon-gamma Release Tests*
Tuberculosis*

Figure

• 

  Fig. 1 A 7×8 cm annular erythematous plaque with central clearing and hyperpigmentation in the left inner thigh.

• 

  Fig. 2 (A) Parakeratosis, acanthosis in epidermis and naked granulomas in the upper to mid-dermis (H&E, ×40). (B) Naked granulomas composed of epithelioid cells (H&E, ×200).

Reference

1. Damevska K, Gocev G. Multifocal tuberculosis verrucosa cutis of 60 years duration. Int J Infect Dis. 2013; 17:e1266–e1267.

2. Sethi A. Fitzpatrick's dermatology in general medicine. In : Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Tuberculosis and infections with atypical mycobacteria. 8th ed. New York: McGraw-Hill;2012. p. 2225–2241.

3. Kardos M, Kimball AB. Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting. J Am Acad Dermatol. 2012; 66:148–152.

4. Koh HY, Tay LK, Pang SM, Ong BH. Changing the way we diagnose tuberculids with interferon gamma release assays. Australas J Dermatol. 2012; 53:73–75.